| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10382 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of COX6A2 mRNA | CTD | PMID:20399798 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10382 | 6480464 | Tetrachlorodibenzodioxin affects the expression of COX6A2 mRNA | CTD | PMID:21570461 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of COX6A2 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | increases expression | ISO | RGD:10382 | 6480464 | Tretinoin results in increased expression of COX6A2 mRNA | CTD | PMID:16788091 PMID:16604517 |
| all-trans-retinoic acid | increases expression | ISO | RGD:10382 | 6480464 | Tretinoin results in increased expression of COX6A2 mRNA | CTD | PMID:16604517 PMID:16788091 |
| ammonium chloride | affects expression | ISO | RGD:2385 | 6480464 | Ammonium Chloride affects the expression of COX6A2 mRNA | CTD | PMID:16483693 |
| antimycin A | increases expression | ISO | RGD:10382 | 6480464 | Antimycin A results in increased expression of COX6A2 mRNA | CTD | PMID:19304788 |
| arsenic atom | affects expression | ISO | RGD:2385 | 6480464 | Arsenic affects the expression of COX6A2 mRNA | CTD | PMID:18315880 |
| arsenic atom | increases expression | ISO | RGD:2385 | 6480464 | Arsenic results in increased expression of COX6A2 mRNA | CTD | PMID:18315880 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of COX6A2 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10382 | 6480464 | Benzo(a)pyrene results in decreased expression of COX6A2 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10382 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of COX6A2 mRNA | CTD | PMID:21715664 |
| C60 fullerene | decreases expression | ISO | RGD:2385 | 6480464 | fullerene C60 results in decreased expression of COX6A2 mRNA | CTD | PMID:19167457 |
| carmustine | decreases expression | EXP | | 6480464 | Carmustine results in decreased expression of COX6A2 mRNA | CTD | PMID:15980968 |
| choline | multiple interactions | ISO | RGD:10382 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COX6A2 mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:10382 | 6480464 | Ciguatoxins affects the expression of COX6A2 mRNA | CTD | PMID:18353800 |
| cisplatin | decreases expression | ISO | RGD:2385 | 6480464 | Cisplatin results in decreased expression of COX6A2 mRNA | CTD | PMID:22023808 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of COX6A2 mRNA | CTD | PMID:20106945 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:10382 | 6480464 | Tetrahydrocannabinol results in increased expression of COX6A2 mRNA | CTD | PMID:21542829 |
| diarsenic trioxide | decreases expression | ISO | RGD:10382 | 6480464 | arsenic trioxide results in decreased expression of COX6A2 mRNA | CTD | PMID:19422848 |
| dibutyl phthalate | increases expression | ISO | RGD:10382 | 6480464 | Dibutyl Phthalate results in increased expression of COX6A2 mRNA | CTD | PMID:21266533 |
| ethanol | decreases expression | ISO | RGD:2385 | 6480464 | Ethanol results in decreased expression of COX6A2 mRNA | CTD | PMID:15353170 |
| folic acid | multiple interactions | ISO | RGD:10382 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COX6A2 mRNA | CTD | PMID:20938992 |
| ketamine | increases expression | ISO | RGD:2385 | 6480464 | Ketamine results in increased expression of COX6A2 mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | ISO | RGD:10382 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COX6A2 mRNA | CTD | PMID:20938992 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2385 | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of COX6A2 mRNA | CTD | PMID:20360939 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:2385 | 6480464 | perfluorooctane sulfonic acid results in increased expression of COX6A2 mRNA | CTD | PMID:22237054 |
| phenobarbital | affects expression | ISO | RGD:10382 | 6480464 | Phenobarbital affects the expression of COX6A2 mRNA | CTD | PMID:23091169 |
| pirinixic acid | decreases expression | ISO | RGD:2385 | 6480464 | pirinixic acid results in decreased expression of COX6A2 mRNA | CTD | PMID:19162173 |
| rotenone | increases expression | ISO | RGD:10382 | 6480464 | Rotenone results in increased expression of COX6A2 mRNA | CTD | PMID:19304788 |
| tetrachloromethane | increases expression | ISO | RGD:10382 | 6480464 | Carbon Tetrachloride results in increased expression of COX6A2 mRNA | CTD | PMID:22386810 |
| tetrachloromethane | multiple interactions | ISO | RGD:10382 | 6480464 | Silymarin inhibits the reaction [Carbon Tetrachloride results in increased expression of COX6A2 mRNA] | CTD | PMID:22386810 |
| zinc atom | decreases expression | ISO | RGD:2385 | 6480464 | Zinc deficiency results in decreased expression of COX6A2 mRNA | CTD | PMID:19111725 |
| zinc(0) | decreases expression | ISO | RGD:2385 | 6480464 | Zinc deficiency results in decreased expression of COX6A2 mRNA | CTD | PMID:19111725 |